Queensland will be at BIOUSA – Booth #5335 – June 2026
Stop by the Australian Pavilion to say G'day!
Queensland Biomedical Sector
Your launchpad to the Asia-Pacific healthcare market
Queensland has tremendous advantages in biomedical and health:
- Asia–Pacific gateway: strategic location, strong trade links and time-zone alignment with key regional markets.
- Clinical trials powerhouse: one of Australia’s largest, fastest and most integrated trial networks with dual-recognised global regulatory pathways and access to R&D incentives.
- Advanced biomanufacturing: home to facilities like ENTRI, TRI’s on-demand cGMP facility, and the Global Translational Science Hub (partnership with Sanofi).
- World-class research: globally recognised strengths in genomics, immunology, medical devices and digital health through the state’s universities and medical research institutes such as QIMR Berghofer. Niche strengths in areas like tropical medicine.
World-class research in Queensland
Why Queensland
Our state is in close proximity to major markets in Asia and with Queensland’s abundant natural resources, existing infrastructure, highly skilled workforce, history of innovation, pro-business environment, and standard of living, there has never been a better time to invest in Queensland.
Five major health and knowledge precincts generating new ideas and technology
Fast, low-cost regulatory pathway
More than 230 biomedical companies employing over 27,000
8 research-focused universities and 9 research hospitals across Queensland
Access to Australia’s research and development tax incentive
Queensland's growing biomedical sector
Queensland’s biomedical sector contributes A$2.9 billion annually* and has grown by 47% since 2017, reflecting strong commercial momentum and increasing global demand for advanced health solutions.
Anchored by world-class institutes such as The University of Queensland’s (UQ) Institute for Molecular Bioscience, the Translational Research Institute (TRI) and QIMR Berghofer.
With integrated university–hospital precincts, advanced biomanufacturing infrastructure and globally connected clinical trials, Queensland offers investors a full value chain, from discovery and design through to manufacturing and export.
*as at December 2025
Credit: Translational Research Institute
Why invest in Queensland's biomedical sector?
Queensland is a fast-growing life sciences hub where biomedical innovation meets global opportunity.
- With strengths across therapeutics, vaccines, diagnostics, medtech, and digital health, Queensland delivers the talent, expertise, and infrastructure needed to accelerate innovation and global market success.
- The state brings together world-class research, a vibrant biotech sector, and advanced clinical infrastructure to drive the next generation of healthcare solutions.
- Backed by strong government support and a highly collaborative ecosystem spanning industry, academia, and health systems, Queensland offers an ideal environment for international partners to co-develop, commercialise, and scale transformative health technologies.
Want to learn more about Queensland’s biomedical investment opportunities?
Medical device manufacturing in Queensland
Biomedical Events and Trade Missions
Get Involved
If you’re an existing client of TIQ, please get in touch with your Client Manager. If you are new to TIQ and looking to learn more about biomedical opportunities, please contact us today.
A destination for clinical trials
Queensland has emerged as one of the emerging destinations for biomedical manufacturing, research and clinical trial with a growing ecosystem across the state led by government, education and industry.
Queensland hosts a state-of-the-art clinical trial network that includes hospitals, research institutions, universities and private enterprise.
Dedicated Health & Knowledge Precincts
Queensland hosts some of Australia’s leading health facilities including Gold Coast Health & Knowledge Precinct, Herston Health Precinct, Boggo Road Innovation Junction, Sunshine Coast Centre for Bioinnovation and Springfield BioPark.
Our unique ecosystem provides space for early-stage companies to undertake discovery research, product development and prototyping.
Queensland Biomedical Exports
Queensland is set to expand its biomedical exports - including vaccines, diagnostics, medical devices, digital health solutions & clinical research services.
If you are operating in the biomedical or health sector and engaging with us for the first time, we encourage you to book a complimentary export consultation.
Queensland’s Biomedical Success Stories
Queensland has an advanced research-informed healthcare system with world class health professionals, renowned researchers and state of the art facilities. Some of the recent Queensland achievements in the health and biomedical sector include:
Vaccine development - Gardasil®
Millions of lives will be saved from cervical cancer by the Human Papilloma Virus (HPV) vaccine Gardasil® that was developed at the University of Queensland by Professor Ian Frazer and the late Dr Jian Zhou to reduce the incidence of cervical cancer. Now produced by Merck Vaccines Gardasil® has led to a 90% decrease in the prevalence of HPV.
Diagnostic imaging
Most of the MRI scanners in the world use magnetic resonance technology research by Queensland Centre for Advanced Imaging. The Translational Research Institute (TRI) collaboration with the Siemens Healthineers enables researchers and clinicians to use advanced medical imaging without the need for invasive testing.
Vaccine development for Malaria
A universal vaccine for Malaria – a disease that annually causes over 200 million clinical episodes and more than 600,000 deaths has been developed by JCU’s Australian Institute for Tropical Health and Medicine (AITHM), is in clinical development in a project led by AITHM in collaboration with Townsville University Hospital, DMTC Ltd and Pfizer.
AI-enabled healthcare
In a project aimed at using AI and whole-genome sequencing to predict patient outcomes of cancer treatment, QIMR Berghofer have partnered with Brisbane-based AI technology company, Max Kelsen, precision analytics firm, genomiQa, genome sequencing company, BGI Australia, and the Royal Brisbane and Women’s Hospital.
Medical devices
The easily stored and administered needle-free vaccine delivery technology developed by researchers at the Australian Institute for Bioengineering and Nanotechnology has been commercialised by UQ spin-off company Vaxxas into their Nanopatch™ High-Density Microarray Patch (HD-MAP).
Personalised medicine
Working to identify cancer-causing genetic mutations for better cancer survival rates, the Australian Translational Genomics Centre is a partnership between QUT, Metro South Hospital and Health Service, and Pathology Queensland, and is one of the largest genomic diagnostic and research DNA sequencing services of its kind in Australasia.